This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DigitalHealth Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.
Daewoong Pharmaceutical , a prominent player in the South Korean pharmaceutical industry, has unveiled its groundbreaking drugdevelopment system, Daewoong AI System (DAISY). About DAISY DAISY represents the culmination of over 40 years of research and development by Daewoong Pharmaceutical.
Biofourmis , a global digitalhealth and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.
The increasing importance of digitalhealth, coupled with abundant capital and supportive regulatory environments, is likely to drive continued M&A activity and higher valuations. Regulatory Environment: Favourable regulatory policies and increased government support for digitalhealth initiatives are fostering innovation.
Merative's product portfolio will focus on six key areas: Health Insights: Providing actionable insights to improve healthcare delivery and decision-making. MarketScan: Offering comprehensive data on healthcare costs and utilisation trends. Subscribe Today!
These developments underscore the ongoing challenges and transformations in both the energy and biotechnology sectors, reflecting broader trends towards sustainability and financial stability. 23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research.
Despite a history of drugdevelopment failures in the field, recent work provides reason for optimism, showing a possible therapeutic arsenal to limit disease progression at an early stage.
Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: DigitalHealth Solutions: The increasing demand for digitalhealth solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.
Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drugdevelopment, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drugdevelopment, but is often characterised by inefficiencies and delays.
Here are some key trends and developments to watch: Key Trends: Technological Advancements: New technologies are revolutionizing wound care, including advanced wound dressings, bioengineered skin substitutes, and innovative wound management devices. Subscribe Today!
Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drugdevelopment processes with the implementation of newer technologies. Office Hours Call 1-917-300-0470 For U.S./
Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions. Artificial Intelligence is utilized in various areas of healthcare, ranging from drugdevelopment to medical image analysis.
–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digitalhealth solutions to better meet the needs of healthcare professionals, regulators and patients. They can view historic data and forecast future trends.
Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. Two trends might be changing the game for private clouds: 1) flat/increased pricing for the public cloud and 2) dropping data center costs.
Exec Summary: DigitalHealth is a subset of Healthtech. DigitalHealth focuses on the individual patient, while Healthtech focuses on the entire healthcare ecosystem. Artificial intelligence: This is a rapidly developing field that has the potential to revolutionize healthcare. Subscribe Today!
Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!
Biopharma Innovation and DrugDevelopment: The development of innovative drugs and therapies remains a key focus in the healthcare industry. Conference attendees discussed the latest trends in biopharma innovation, including gene therapy, cell therapy, and antibody-drug conjugates. Subscribe Today!
However, only 46% consider the information they send to the National Health Service to be secure, and only 40% would be willing to share information digitally with providers who aren’t part of the NHS system.
Exec Summary: The pain management market is experiencing exciting growth, driven by several key trends: Increased Demand: Chronic pain prevalence: Chronic pain affects a significant portion of the population, with an aging demographic further increasing demand. Subscribe Today!
The market for digitalhealth is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digitalhealth was still in its early stages. However, the market has matured since then, and there are now a number of other digitalhealth companies competing with Teladoc.
Bardy Diagnostics is a digitalhealth and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.
Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Palantir's software is able to identify patterns and trends in data.
Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drugdevelopment The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.
The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of DigitalHealth’ (GIDH) in August, proclaiming: “Digitalhealth is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”
These algorithms can analyse vast amounts of medical data, including patient history, lab results, imaging scans, and genetic information, to identify patterns and trends that would be difficult for humans to see. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis.
It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Data analysis to identify trends and patterns, aiding in resource allocation.
HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, DigitalHealth Insights and Analysis. Healthcare AI can leverage similar techniques to analyse patient data and predict: Disease risks Potential complications Individual healthtrends This enables proactive interventions and personalised care plans.
This trend initially picked up because of the pandemic, but it’s here to stay as a component of healthcare offerings for the convenience that it offers. The majority of respondents in our recent Patient Experience survey shared that they are happy to have online consultations about their health, except for things like physical injuries.
Valerie Reich, VP of Healthcare Strategy at Hero Digital In 2025, healthcare will continue evolving into a connected network of services centered around the consumer. This collaboration will drive innovations such as faster drugdevelopment and coordinated patient care.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content